HemaSphere (Jun 2022)
P1115: A MULTICENTER PHASE 1/2 TRIAL OF EO2463, A MICROBIAL-DERIVED PEPTIDE THERAPEUTIC VACCINE, AS MONOTHERAPY AND IN COMBINATION WITH LENALIDOMIDE AND RITUXIMAB, FOR TREATMENT OF PATIENTS WITH INDOLENT NHL
- P. L. Zinzani,
- S. M. Ansell,
- F. Bosch,
- J. W. Friedberg,
- J. P. Marolleau,
- L. Arcaini,
- R. Garcia-Sanz,
- A. K. Gopal,
- C. Grande,
- R. Merryman,
- A. Pinto,
- S. D. Smith,
- J. C. Villasboas,
- D. Wallace,
- J. Fagerberg,
- J. G. Magalhaes,
- P. Armand
Affiliations
- P. L. Zinzani
- 1 Institute of Hematology “L. e A. Seràgnoli”, University of Bologna, Bologna, Italy
- S. M. Ansell
- 2 Division of Hematology, Mayo Clinic, Rochester, United States of America
- F. Bosch
- 3 Department of Hematology, Vall d’Hebron Institute of Oncology, Barcelona, Spain
- J. W. Friedberg
- 4 University of Rochester Medical Center, Rochester, United States of America
- J. P. Marolleau
- 5 CHU Amiens, Amiens, France
- L. Arcaini
- 6 Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
- R. Garcia-Sanz
- 7 Hospital Universitario de Salamanca, Salamanca, Spain
- A. K. Gopal
- 8 Division of Medical Oncology, University of Washington, Seattle, United States of America
- C. Grande
- 9 Universidad de Navarra, Madrid and Pamplona, Spain
- R. Merryman
- 10 Dana-Farber Cancer Institute, Boston, United States of America
- A. Pinto
- 11 Istituto Nazionale Tumori “Fondazione G.Pascale”- IRCCS, Naples, Italy
- S. D. Smith
- 12 University of Washington/Fred Hutchinson Cancer Research Center, Seattle
- J. C. Villasboas
- 2 Division of Hematology, Mayo Clinic, Rochester, United States of America
- D. Wallace
- 13 Department of Medicine, University of Rochester, Rochester, United States of America
- J. Fagerberg
- 14 Enterome, Paris, France
- J. G. Magalhaes
- 14 Enterome, Paris, France
- P. Armand
- 10 Dana-Farber Cancer Institute, Boston, United States of America
- DOI
- https://doi.org/10.1097/01.HS9.0000847328.48663.29
- Journal volume & issue
-
Vol. 6
pp. 1005 – 1006
Abstract
No abstracts available.